Further analysis indicated that SOCS3 promotes the expansion of Th17/IFN-γ CD4 T cell populations, implicating SOCS3 in the progression of severe uveitis and framing it as a potential target for medicinal chemistry campaigns targeting uveitis and other autoimmune diseases (84). This evidence concerns the gene IFNG and uveitis.